Ming Liu1, Charlotte M Druschel2, Edward L Hannan3. 1. Bureau of Environmental and Occupational Epidemiology, Center for Environmental Health, New York State Department of Health, Albany, New York. Electronic address: mx137@health.state.ny.us. 2. Bureau of Environmental and Occupational Epidemiology, Center for Environmental Health, New York State Department of Health, Albany, New York; School of Public Health, University at Albany, State University of New York, Albany, New York. 3. School of Public Health, University at Albany, State University of New York, Albany, New York.
Abstract
BACKGROUND: Morbid events after pediatric congenital cardiac surgery are increasingly used for better outcome measurement and quality comparisons. This study was undertaken to evaluate the relationship between a hospital's risk-adjusted prevalence of prolonged postoperative length of stay (PLOS) and its risk-adjusted mortality rate to investigate whether PLOS can serve as an appropriate quality measure for pediatric congenital cardiac surgery. METHODS: Risk-adjusted prevalence of prolonged PLOS for 12 programs in New York State was estimated using data from 4,776 operations in the New York State pediatric Cardiac Surgery Reporting System (2006-2009). We used logistic regression analysis to adjust for case mix and patient risk factors. The hospital-level correlation between risk-adjusted prolonged PLOS and risk-adjusted mortality rates was examined using Spearman correlation coefficient analysis. RESULTS: Risk-adjusted prevalence of prolonged PLOS ranged from 7.48% to 36.52% for pediatric cardiac programs in New York State during the study period. The Spearman correlation test showed a strong positive relationship between a hospital's risk-adjusted prolonged PLOS and mortality rate (r = 0.83; p = 0.0008). CONCLUSIONS: Prolonged PLOS can be used in lieu of risk-adjusted mortality rates when it is not practical to use mortality rates owing to low case volume or decreasing mortality rates of some procedures.
BACKGROUND: Morbid events after pediatric congenital cardiac surgery are increasingly used for better outcome measurement and quality comparisons. This study was undertaken to evaluate the relationship between a hospital's risk-adjusted prevalence of prolonged postoperative length of stay (PLOS) and its risk-adjusted mortality rate to investigate whether PLOS can serve as an appropriate quality measure for pediatric congenital cardiac surgery. METHODS: Risk-adjusted prevalence of prolonged PLOS for 12 programs in New York State was estimated using data from 4,776 operations in the New York State pediatric Cardiac Surgery Reporting System (2006-2009). We used logistic regression analysis to adjust for case mix and patient risk factors. The hospital-level correlation between risk-adjusted prolonged PLOS and risk-adjusted mortality rates was examined using Spearman correlation coefficient analysis. RESULTS: Risk-adjusted prevalence of prolonged PLOS ranged from 7.48% to 36.52% for pediatric cardiac programs in New York State during the study period. The Spearman correlation test showed a strong positive relationship between a hospital's risk-adjusted prolonged PLOS and mortality rate (r = 0.83; p = 0.0008). CONCLUSIONS: Prolonged PLOS can be used in lieu of risk-adjusted mortality rates when it is not practical to use mortality rates owing to low case volume or decreasing mortality rates of some procedures.
Authors: Peter F Ehrlich; Thomas E Hamilton; Kenneth Gow; Douglas Barnhart; Fernando Ferrer; Jessica Kandel; Richard Glick; Roshni Dasgupta; Arlene Naranjo; Ying He; Elizabeth J Perlman; John A Kalapurakal; Geetika Khanna; Jeffrey S Dome; James Geller; Elizabeth Mullen Journal: Pediatr Blood Cancer Date: 2016-05-27 Impact factor: 3.167
Authors: Angira Patel; John M Costello; Carl L Backer; Sara K Pasquali; Kevin D Hill; Amelia S Wallace; Jeffrey P Jacobs; Marshall L Jacobs Journal: Ann Thorac Surg Date: 2016-06-17 Impact factor: 4.330
Authors: Stefanie G Ames; Billie S Davis; Derek C Angus; Joseph A Carcillo; Jeremy M Kahn Journal: Pediatr Crit Care Med Date: 2018-05 Impact factor: 3.624
Authors: Laura Mercer-Rosa; Okan U Elci; Grace DeCost; Stacy Woyciechowski; Sharon M Edman; Chitra Ravishankar; Christopher E Mascio; Steven M Kawut; Elizabeth Goldmuntz Journal: J Am Heart Assoc Date: 2018-05-16 Impact factor: 5.501